carboplatin,durvalumab,gemcitabine,paclitaxel,vinorelbine,cisplatin,nivolumab,docetaxel,pemetrexed,ipilimumab,pembrolizumab
astrazeneca,merck,bms
['keynote671', 'key,note,62', 'keynote,671', 'aegean', 'cm816', 'cisplatin', 'lcsm,(-blcsm)']
keynote671: double blind rct; only cisplatin regimens ; 3/4 completed 4cycles; about 20% never operated ; 40% completed 1y; pneumonectomy rate same; 2yefs landmark 62% seems same as aegean and cm816. makes me doubt the post op io adds much #asco23 #lcsm 
Consultant Medical Oncologist, UK. Views are hypothesis generating discourse. Post COVID dabbling in garden.